Samsara-Biocapital

AI_NATIVE detailed information: This accession holds the following tickers:[
  "ABVX",
  "PRME",
  "AVDL",
  "SLRN",
  "TNGX",
  "TERN",
  "LENZ",
  "MLYS",
  "NGNE",
  "ALMS",
  "ALLK",
  "ARTV",
  "BOLT",
  "CTNM",
  "SRRK",
  "LPTX",
  "NKTX",
  "PVLA",
  "OKUR",
  "SEPN",
  "SRZN",
  "STRO",
  null,
  null,
  "ZYME",
  "UPB",
  "LYRA",
  "RYTM",
  "ACLX",
  "GOSS",
  "CRIS",
  "HLVX",
  "INZY",
  "KLRS",
  "KRON",
  "VTVT",
  "CRGX"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 37
Total Value: 560807077
Accession Number: 0001415889-25-013106
Form Type: 13F-HR
CIK: samsara-biocapital
Manager Name: Samsara-Biocapital

Data Enrichment

95% identified

35 identified2 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

37 positions • $560.8M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 1 of 2

Sort by:

Scholar Rock Holding Corp

SRRK|80706P103

Shares:5.6M

Value:$180.5M

% of Portfolio:32.2% ($180.5M/$560.8M)

Kalaris Therapeutics, Inc.

KLRS|482929106

Shares:11.4M

Value:$91.9M

% of Portfolio:16.4% ($91.9M/$560.8M)

Mineralys Therapeutics, Inc.

MLYS|603170101

Shares:5.7M

Value:$90.1M

% of Portfolio:16.1% ($90.1M/$560.8M)

Neurogene Inc.

NGNE|64135M105

Shares:1.7M

Value:$20.1M

% of Portfolio:3.6% ($20.1M/$560.8M)

ALUMIS INC.

ALMS|022307102

Shares:3.3M

Value:$20.1M

% of Portfolio:3.6% ($20.1M/$560.8M)

PALVELLA THERAPEUTICS, INC.

PVLA|697947109

Shares:679.5K

Value:$19.0M

% of Portfolio:3.4% ($19.0M/$560.8M)

Septerna, Inc.

SEPN|81734D104

Shares:3.1M

Value:$18.2M

% of Portfolio:3.3% ($18.2M/$560.8M)

CARGO Therapeutics, Inc.

CRGX|14179K101

Shares:4.4M

Value:$18.0M

% of Portfolio:3.2% ($18.0M/$560.8M)

LENZ Therapeutics, Inc.

LENZ|52635N103

Shares:526.4K

Value:$13.5M

% of Portfolio:2.4% ($13.5M/$560.8M)

Upstream Bio, Inc.

UPB|91678A107

Shares:2.1M

Value:$12.7M

% of Portfolio:2.3% ($12.7M/$560.8M)

Arcellx, Inc.

ACLX|03940C100

Shares:135.3K

Value:$8.9M

% of Portfolio:1.6% ($8.9M/$560.8M)

Zymeworks Inc.

ZYME|98985Y108

Shares:666.7K

Value:$7.9M

% of Portfolio:1.4% ($7.9M/$560.8M)

AVADEL PHARMACEUTICALS PLC

AVDL|G29687103

Shares:967.5K

Value:$7.6M

% of Portfolio:1.4% ($7.6M/$560.8M)

RHYTHM PHARMACEUTICALS, INC.

RYTM|76243J105

Shares:138.1K

Value:$7.3M

% of Portfolio:1.3% ($7.3M/$560.8M)

Nkarta, Inc.

NKTX|65487U108

Shares:3.8M

Value:$6.9M

% of Portfolio:1.2% ($6.9M/$560.8M)

Gossamer Bio, Inc.

GOSS|38341P102

Shares:6.1M

Value:$6.7M

% of Portfolio:1.2% ($6.7M/$560.8M)

ACELYRIN, Inc.

SLRN|00445A100

Shares:2.5M

Value:$6.2M

% of Portfolio:1.1% ($6.2M/$560.8M)

Contineum Therapeutics, Inc.

CTNM|21217B100

Shares:588.8K

Value:$4.1M

% of Portfolio:0.7% ($4.1M/$560.8M)

vTv Therapeutics Inc.

VTVT|918385204

Shares:206.8K

Value:$3.6M

% of Portfolio:0.6% ($3.6M/$560.8M)

OnKure Therapeutics, Inc.

OKUR|68277Q105

Shares:824.2K

Value:$3.5M

% of Portfolio:0.6% ($3.5M/$560.8M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Scholar Rock Holding Corp(SRRKcusip80706P103)	5.6M	QoQ 0.00% (-0) YoY -17.31% (-1.2M)	All Managers (Combined)	$180.5M	32.2% ($180.5M/$560.8M)	QoQ -25.61% (-$62.1M) YoY +49.67% (-$59.9M)
Kalaris Therapeutics, Inc.(KLRScusip482929106)	11.4M	QoQ NEW(+11.4M) YoY NEW(+11.4M)	All Managers (Combined)	$91.9M	16.4% ($91.9M/$560.8M)	QoQ NEW(+$91.9M) YoY NEW(+$91.9M)
Mineralys Therapeutics, Inc.(MLYScusip603170101)	5.7M	QoQ +11.82% (+600.0K) YoY +11.82% (+600.0K)	All Managers (Combined)	$90.1M	16.1% ($90.1M/$560.8M)	QoQ +44.25% (+$27.6M) YoY +37.54% (+$24.6M)
Neurogene Inc.(NGNEcusip64135M105)	1.7M	QoQ 0.00% (-0) YoY +35.44% (-449.3K)	All Managers (Combined)	$20.1M	3.6% ($20.1M/$560.8M)	QoQ -48.77% (-$19.1M) YoY -68.84% (-$44.4M)
ALUMIS INC.(ALMScusip022307102)	3.3M	QoQ 0.00% (-0) YoY NEW(+3.3M)	All Managers (Combined)	$20.1M	3.6% ($20.1M/$560.8M)	QoQ -21.88% (-$5.6M) YoY NEW(+$20.1M)
PALVELLA THERAPEUTICS, INC.(PVLAcusip697947109)	679.5K	QoQ 0.00% (+0) YoY NEW(+679.5K)	All Managers (Combined)	$19.0M	3.4% ($19.0M/$560.8M)	QoQ +133.24% (+$10.9M) YoY NEW(+$19.0M)
Septerna, Inc.(SEPNcusip81734D104)	3.1M	QoQ +13.74% (-380.6K) YoY NEW(+3.1M)	All Managers (Combined)	$18.2M	3.3% ($18.2M/$560.8M)	QoQ -71.24% (-$45.2M) YoY NEW(+$18.2M)
CARGO Therapeutics, Inc.(CRGXcusip14179K101)	4.4M	QoQ 0.00% (-0) YoY +7.13% (-294.0K)	All Managers (Combined)	$18.0M	3.2% ($18.0M/$560.8M)	QoQ -71.77% (-$45.7M) YoY -80.46% (-$74.0M)
LENZ Therapeutics, Inc.(LENZcusip52635N103)	526.4K	QoQ -46.66% (-460.6K) YoY -56.44% (-682.1K)	All Managers (Combined)	$13.5M	2.4% ($13.5M/$560.8M)	QoQ -52.50% (-$15.0M) YoY -49.84% (-$13.5M)
Upstream Bio, Inc.(UPBcusip91678A107)	2.1M	QoQ -6.76% (-150.0K) YoY NEW(+2.1M)	All Managers (Combined)	$12.7M	2.3% ($12.7M/$560.8M)	QoQ -65.29% (-$23.8M) YoY NEW(+$12.7M)
Arcellx, Inc.(ACLXcusip03940C100)	135.3K	QoQ -46.66% (-118.4K) YoY -70.17% (-318.4K)	All Managers (Combined)	$8.9M	1.6% ($8.9M/$560.8M)	QoQ -54.37% (-$10.6M) YoY -71.87% (-$22.7M)
Zymeworks Inc.(ZYMEcusip98985Y108)	666.7K	QoQ -33.33% (-333.3K) YoY -54.30% (-792.2K)	All Managers (Combined)	$7.9M	1.4% ($7.9M/$560.8M)	QoQ -45.76% (-$6.7M) YoY -48.26% (-$7.4M)
AVADEL PHARMACEUTICALS PLC(AVDLcusipG29687103)	967.5K	QoQ 0.00% (-0) YoY NEW(+967.5K)	All Managers (Combined)	$7.6M	1.4% ($7.6M/$560.8M)	QoQ -25.49% (-$2.6M) YoY NEW(+$7.6M)
RHYTHM PHARMACEUTICALS, INC.(RYTMcusip76243J105)	138.1K	QoQ -19.99% (-34.5K) YoY -19.99% (-34.5K)	All Managers (Combined)	$7.3M	1.3% ($7.3M/$560.8M)	QoQ -24.30% (-$2.3M) YoY -2.20% (-$164.7K)
Nkarta, Inc.(NKTXcusip65487U108)	3.8M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$6.9M	1.2% ($6.9M/$560.8M)	QoQ -26.10% (-$2.4M) YoY -82.97% (-$33.8M)
Gossamer Bio, Inc.(GOSScusip38341P102)	6.1M	QoQ 0.00% (+0) YoY 0.00% (-0)	All Managers (Combined)	$6.7M	1.2% ($6.7M/$560.8M)	QoQ +21.60% (+$1.2M) YoY -6.77% (-$490.4K)
ACELYRIN, Inc.(SLRNcusip00445A100)	2.5M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$6.2M	1.1% ($6.2M/$560.8M)	QoQ -21.33% (-$1.7M) YoY -63.40% (-$10.8M)
Contineum Therapeutics, Inc.(CTNMcusip21217B100)	588.8K	QoQ 0.00% (-0) YoY NEW(+588.8K)	All Managers (Combined)	$4.1M	0.7% ($4.1M/$560.8M)	QoQ -52.35% (-$4.5M) YoY NEW(+$4.1M)
vTv Therapeutics Inc.(VTVTcusip918385204)	206.8K	QoQ 0.00% (+0) YoY 0.00% (-0)	All Managers (Combined)	$3.6M	0.6% ($3.6M/$560.8M)	QoQ +25.42% (+$726.1K) YoY -26.39% (-$1.3M)
OnKure Therapeutics, Inc.(OKURcusip68277Q105)	824.2K	QoQ 0.00% (-0) YoY NEW(+824.2K)	All Managers (Combined)	$3.5M	0.6% ($3.5M/$560.8M)	QoQ -49.99% (-$3.5M) YoY NEW(+$3.5M)